Fundamental Analysis
76 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +121.9% | +896.3% | 3 / 3 | -32.9% | +5.32 pp | +6.05 pp | +33.9% | 1.24 | 2.24 | 1.309 | −32,9% | 24,8 | +130,5% | 2.24 | 0.74 | +203,2% |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 12 | 6 | 4 | |||||||
Valuation annotation:Price: 9.870 (close price on 2026-10-19)EPS (TTM): 4.399
Financial charts
1.Revenue & growth
VND bn1.309Q2/26
1.Revenue & growth
VND bn1.309Q2/26
2.Profit & growth
VND bn22,8Q2/26
3.Profit mix (Penman)
VND bn361Q2/26
4.Margins & cost structure
%1.2%Q2/26
5.Returns & cash cycle
% · days-10.7%Q2/26
6.Earnings quality & cash
VND bn282Q2/26
7.Asset structure
VND bn3.600Q2/26
8.Funding & debt health
VND bn · times3.600Q2/26
9.Revenue backlog
VND bn68,5Q2/26
10.Valuation
times · %2,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %309Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
884%
averaged over 1 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26